Jen Higgs describes her experience of delirium and how healthcare professionals can advocate for patients unable to speak up ...

CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved for the treatment of patients with multiple myeloma who have had at least one prior line of therapy. Globally, CARVYKTI ® is ...

Dealing with an infection isn't as straightforward as simply killing the pathogen. The body also needs to carefully steer and ...

Griffith University researchers may have unlocked the secret to treating sepsis, with a Phase II clinical trial in China ...

On November 2, 2025, the research group led by Dr. Zeng Ling from Army Medical University systematically elucidated the molecular mechanisms, ...

Lactated Ringers Injection Market to reach USD 2.9 Bn by 2036, driven by rising hospital admissions, increasing surgical ...

STOCKHOLM, Jan. 7, 2026 /PRNewswire/ — Sobi® (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant® (emapalumab) for interferon-gamma (IFNγ)-driven ...

Sepsis, a complex syndrome driven by a dysregulated host response to infection, is closely linked to both metabolic and ...

Sepsis is a life-threatening condition that is caused by an excessive immune response to an infection, most commonly a bacterial infection. Sepsis can lead to multi-organ failure and death. Immune ...

The intravascular temperature management market is positioned for sustained expansion driven by escalating clinical demand ...

The Lancet Commission on a Citizen-Centred Health System for India presents a timely and comprehensive assessment of India's health system.1 Although noting India's progress in reducing infant and ...